相关实验视频
Updated: Jul 4, 2025

10:10
Reverse Total Shoulder Arthroplasty
Published on: July 5, 2011
43.2K
在患有痴呆症或轻度认知障碍的患者中进行全肩关节整形手术
Juan Serna1, Favian Su1, Drew A Lansdown1
1Department of Orthopaedic Surgery, University of California San Francisco, San Francisco, CA, USA.
JSES international
|February 5, 2024
概括
患有痴呆症或轻度认知障碍,接受全肩关节整形手术的患者面临更高的手术和医疗并发症风险. 需要对这些患者进行仔细考虑,以尽量减少不良结果.
科学领域:
- 整形外科手术 整形外科手术
- 神经外科 神经外科
- 老年医学 老年医学
背景情况:
- 解剖学全肩关节整形术 (ATSA) 和逆向全肩关节整形术 (RTSA) 是治疗肩部疼痛和功能障碍的常见手术.
- 关于这些手术在神经认知障碍患者的结果的研究有限.
研究的目的:
- 研究神经认知障碍 (痴呆或轻度认知障碍 (MCI)) 与ATSA和RTSA后手术和医疗并发症的风险之间的关联.
主要方法:
- 对PearlDiver数据库 (2010-2021) 的回顾性审查确定了接受ATSA或RTSA治疗的患者,并进行了至少2年的随访.
- 患者被分为三组:痴呆症,MCI和没有神经认知障碍.
- 在各组中比较了手术和医疗并发症的发生率.
主要成果:
- 接受RTSA治疗的痴呆症患者患上周围假肢手臂骨折,假肢不稳定性和修复手术的几率增加.
- 患有MCI的ATSA患者表现出更高的假肢不稳定的几率.
- 患有神经认知障碍的患者患病并发症的几率较高,包括心肌梗塞和脑血管事故.
结论:
- 患有痴呆症的RTSA患者和患有MCI的ATSA患者面临更多的手术并发症风险.
- 患有MCI或痴呆症的ATSA和RTSA患者都有更高的医学并发症风险.
- 对于接受肩关节整形手术的神经认知障碍患者来说,特别注意和仔细讨论风险至关重要.
更多相关视频
09:51The Transition to an Anterior-Based Muscle Sparing Approach Improves Early Postoperative Function but is Associated with a Learning Curve
Published on: September 7, 2022
2.6K
07:45The Use of Mixed Reality in Custom-Made Revision Hip Arthroplasty: A First Case Report
Published on: August 4, 2022
3.4K
相关概念视频
Dementia
115
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
115
Alzheimer's Disease: Treatment
193
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
193
Alzheimer's Disease: Overview
487
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
487